Cd19 Specific Chimeric Antigen Receptor And Uses Thereof

Patent No. EP2997141 (titled "Cd19 Specific Chimeric Antigen Receptor And Uses Thereof") was filed by Cellectis on May 12, 2014. The application was issued on Oct 12, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACOPATJul 12, 2023IZQUIERDO BLANCO

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2997141

CELLECTIS
Application Number
EP14723436A
Filing Date
May 12, 2014
Status
Granted And Under Opposition
Sep 9, 2022
Publication Date
Oct 12, 2022